April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 11, 2025

Doctors Never Truly Vacation, Study Reveals

"Organizations should implement strategies to minimize clinical tasks during PTO."

Conexiant

May 08, 2024

ObGyn Harassment Prevalence Exposed in Revealing Review

Discover key insights from a systematic review on harassment among ObGyn health care professionals.

Conexiant

August 09, 2024

Updated Guidance on Contraceptive Use

The CDC has released updated contraceptive guidance for health care providers, emphasizing patient autonomy and evidence-based recommendations to support high-quality, equitable contraceptive care.

Conexiant

June 13, 2024

Role of Embryo Freezing in IVF: An Explainer

In 2021, over 80% of U.S. in vitro fertilization procedures involved the transfer of frozen embryos, potentially reducing uncertainties, delays, and costs in comparison to fresh embryos.

Reuters

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant